DE69731834T2 - Agouti verwandtes gen - Google Patents

Agouti verwandtes gen Download PDF

Info

Publication number
DE69731834T2
DE69731834T2 DE69731834T DE69731834T DE69731834T2 DE 69731834 T2 DE69731834 T2 DE 69731834T2 DE 69731834 T DE69731834 T DE 69731834T DE 69731834 T DE69731834 T DE 69731834T DE 69731834 T2 DE69731834 T2 DE 69731834T2
Authority
DE
Germany
Prior art keywords
polypeptide
art
seq
nucleic acid
acid molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69731834T
Other languages
German (de)
English (en)
Other versions
DE69731834D1 (de
Inventor
Lee Kevin STARK
Roland Luethy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of DE69731834D1 publication Critical patent/DE69731834D1/de
Application granted granted Critical
Publication of DE69731834T2 publication Critical patent/DE69731834T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
DE69731834T 1996-05-10 1997-04-22 Agouti verwandtes gen Expired - Fee Related DE69731834T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1750596P 1996-05-10 1996-05-10
US17505P 1996-05-10
US757541 1996-11-27
US08/757,541 US5766877A (en) 1996-05-10 1996-11-27 Genes encoding art, an agouti-related transcript
PCT/US1997/006853 WO1997043412A1 (en) 1996-05-10 1997-04-22 Novel agouti-related gene

Publications (2)

Publication Number Publication Date
DE69731834D1 DE69731834D1 (de) 2005-01-05
DE69731834T2 true DE69731834T2 (de) 2005-12-15

Family

ID=26689965

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69731834T Expired - Fee Related DE69731834T2 (de) 1996-05-10 1997-04-22 Agouti verwandtes gen

Country Status (12)

Country Link
US (5) US5766877A (cg-RX-API-DMAC10.html)
EP (1) EP0917571B1 (cg-RX-API-DMAC10.html)
JP (1) JP4219404B2 (cg-RX-API-DMAC10.html)
AT (1) ATE283917T1 (cg-RX-API-DMAC10.html)
AU (1) AU2681497A (cg-RX-API-DMAC10.html)
CA (1) CA2253238C (cg-RX-API-DMAC10.html)
DE (1) DE69731834T2 (cg-RX-API-DMAC10.html)
DK (1) DK0917571T3 (cg-RX-API-DMAC10.html)
ES (1) ES2234015T3 (cg-RX-API-DMAC10.html)
PT (1) PT917571E (cg-RX-API-DMAC10.html)
SI (1) SI0917571T1 (cg-RX-API-DMAC10.html)
WO (1) WO1997043412A1 (cg-RX-API-DMAC10.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6310034B1 (en) 1993-05-21 2001-10-30 Ut-Battelle, Llc Agouti polypeptide compositions
US5843652A (en) * 1993-05-21 1998-12-01 Lockheed Martin Energy Systems, Inc. Isolation and characterization of Agouti: a diabetes/obesity related gene
US5766877A (en) * 1996-05-10 1998-06-16 Amgen Inc. Genes encoding art, an agouti-related transcript
EP0942967A1 (en) * 1996-11-06 1999-09-22 Children's Medical Center Corporation Transgenic animal expressing a syndecan in the regions of hypothalamus
US6878520B1 (en) * 1997-12-16 2005-04-12 Merck & Co., Inc. C-terminal region of agouti-related transcript (ART) protein
WO1999031508A1 (en) * 1997-12-16 1999-06-24 Merck & Co., Inc. C-terminal region of agouti-related transcript (art) protein
WO1999050295A2 (en) * 1998-03-30 1999-10-07 Gryphon Sciences Agouti-related protein analogs and methods of use
US6689873B1 (en) 1998-04-29 2004-02-10 Merck & Co., Inc. Nucleic acid encoding rat agouti related protein
CA2340323A1 (en) * 1998-09-03 2000-03-16 Ronald Duman Mc4-r as target for the identification of compounds used to treat drug addiction
US6716810B1 (en) * 1998-12-09 2004-04-06 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
US6603058B1 (en) 1998-12-09 2003-08-05 Oklahoma Medical Research Foundation Non-human animal model for obesity and uses thereof
US6303749B1 (en) 1999-01-29 2001-10-16 Amgen Inc. Agouti and agouti-related peptide analogs
US20030064921A1 (en) * 1999-10-27 2003-04-03 The Regents Of The University Of California Methods and compounds for modulating melanocortin receptor ligand binding and activity
EP1125579A3 (en) 2000-01-18 2003-01-02 Pfizer Products Inc. Uses of agrp-melanocortin receptor binding modulating compounds
US6541585B2 (en) * 2000-05-31 2003-04-01 E. I. Du Pont De Nemours And Company Polymerization of olefins
AU2002238106A1 (en) * 2001-02-13 2002-08-28 Palatin Technologies, Inc. Melanocortin metallopeptides for treatment of sexual dysfunction
WO2002081443A1 (en) * 2001-04-09 2002-10-17 Chiron Corporation Novel guanidino compounds
US20030207814A1 (en) * 2002-02-04 2003-11-06 Chiron Corporation Novel guanidinyl derivatives
US20050124652A1 (en) * 2002-02-04 2005-06-09 Rustum Boyce Guanidino compounds
US20030195187A1 (en) * 2002-02-04 2003-10-16 Chiron Corporation Guanidino compounds
US20070004743A1 (en) * 2002-02-25 2007-01-04 Xiao Linda L Intranasal administration of mc4-r agonists
PT1551834E (pt) * 2002-05-23 2010-09-30 Novartis Vaccines & Diagnostic Compostos de quinazolinona substituídos
JP2006506968A (ja) * 2002-07-03 2006-03-02 メルク エンド カムパニー インコーポレーテッド アグーチ関連蛋白質欠損細胞、非ヒトトランスジェニック動物及びエネルギー代謝を調節する化合物の選択方法
EP1651229A1 (en) * 2003-05-23 2006-05-03 Chiron Corporation Guanidino-substituted quinazolinone compounds as mc4-r agonists
SI1656455T1 (sl) * 2003-08-13 2012-12-31 Sandoz Ag Postopek za čiščenje rekombinantnih polipeptidov
US7368453B2 (en) * 2003-11-19 2008-05-06 Chiron Corporation Quinazolinone compounds with reduced bioaccumulation
US6974187B2 (en) * 2004-01-28 2005-12-13 Tachi-S Co., Ltd. Vehicle seat structure
NZ550114A (en) * 2004-04-20 2011-02-25 Transtech Pharma Inc Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
US7910101B2 (en) 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
US20070021433A1 (en) 2005-06-03 2007-01-25 Jian-Qiang Fan Pharmacological chaperones for treating obesity
US7833927B2 (en) * 2005-08-31 2010-11-16 Rohm And Haas Company Single site palladium catalyst complexes
WO2010025142A1 (en) * 2008-08-29 2010-03-04 Transtech Pharma, Inc. Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use
WO2012100342A1 (en) 2011-01-27 2012-08-02 Université de Montréal Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4263428A (en) * 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
DE3169595D1 (en) * 1980-11-10 1985-05-02 Gersonde Klaus Method of preparing lipid vesicles by ultrasonic treatment, the use of this method and apparatus for its application
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
EP0088046B1 (de) * 1982-02-17 1987-12-09 Ciba-Geigy Ag Lipide in wässriger Phase
EP0143949B1 (en) * 1983-11-01 1988-10-12 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Pharmaceutical composition containing urokinase
DE3572982D1 (en) * 1984-03-06 1989-10-19 Takeda Chemical Industries Ltd Chemically modified lymphokine and production thereof
EP0401384B1 (en) * 1988-12-22 1996-03-13 Kirin-Amgen, Inc. Chemically modified granulocyte colony stimulating factor
US5252714A (en) * 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
US5766877A (en) * 1996-05-10 1998-06-16 Amgen Inc. Genes encoding art, an agouti-related transcript

Also Published As

Publication number Publication date
US5766877A (en) 1998-06-16
DK0917571T3 (da) 2005-03-14
EP0917571B1 (en) 2004-12-01
US6203995B1 (en) 2001-03-20
JP4219404B2 (ja) 2009-02-04
EP0917571A1 (en) 1999-05-26
ES2234015T3 (es) 2005-06-16
SI0917571T1 (en) 2005-06-30
CA2253238A1 (en) 1997-11-20
US7122520B2 (en) 2006-10-17
DE69731834D1 (de) 2005-01-05
JP2001517931A (ja) 2001-10-09
ATE283917T1 (de) 2004-12-15
US20030082737A1 (en) 2003-05-01
US6060589A (en) 2000-05-09
CA2253238C (en) 2008-08-12
PT917571E (pt) 2005-04-29
WO1997043412A1 (en) 1997-11-20
AU2681497A (en) 1997-12-05
US20010007752A1 (en) 2001-07-12

Similar Documents

Publication Publication Date Title
US5766877A (en) Genes encoding art, an agouti-related transcript
DE69334201T2 (de) Dominant-negativer Membran-gebundener Flk-1 Rezeptor des vaskulären Endothelzellen-Wachstumsfaktors VEGF
DE69629181T2 (de) Wachstumsfaktor-b, spezifisch für vaskuläre endothelzellen
DE60217507T2 (de) Peptide für die behandlung von tumoren und anderen zuständen, die das entfernen oder zerstören von zellen erfordern
DE69936315T2 (de) Fragmente des wachstumsfaktors für bindegewebe (ctgf) und verfahren und anwendungen davon
DE69926536T2 (de) Antagonisten von vaskular-endothelialen zellwachstumsfaktoren und ihre anwendung
DE69737266T2 (de) Ob-fusionsprotein enthaltende zusammensetzungen und verfahren
DE69331832T2 (de) Diagnostische verfahren und pharmazeutische zusammensetzungen auf der basis von notch-proteinen und nukleinsäuren
DE69736597T2 (de) Gdnf rezeptor
DE69121208T2 (de) Neuer neurotropischer faktor
DE69635675T2 (de) Verkürzter aus einer gliazelllinie gewonnener neurotropher faktor
DE69932510T2 (de) Vaskularisierungsinhibitoren
DE60027409T2 (de) Glykosylierte leptinzusammensetzungen und zugehörige verfahren
DE60118382T2 (de) Protoonkogen aus menschlichem Zervikalkarzinom 2 und darin kodiertes Protein
DE60034871T2 (de) Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust
DE69838905T2 (de) Transkriptionsfaktor islet-brain 1 (ib1)
DE60223511T2 (de) Neurotrophe faktoren
DE69132814T2 (de) Neues insulinähnliches wachstumsfaktor bindendes protein igfbp-5
DE69837085T2 (de) Crsp-proteine (cystein-reiche, sekretierte proteine), die dafür kodierenden nukleinsäuren und ihre verwendungen
DE60019147T2 (de) Fibrinolytisch wirksames polypeptid
DE69836428T2 (de) Karzinostatische wirkstoffe
DE69934239T2 (de) Ly6h-gen
DE69734096T2 (de) Rezeptor des ob-proteins und verwandte zusammensetzungen und verfahren
DE69924009T2 (de) Methode zur verstärkung der biologischen aktivität von liganden
DE69937570T2 (de) Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee